» Articles » PMID: 20189863

Risk Factors and Prevalence of Tuberculosis, Human Immunodeficiency Virus, Syphilis, Hepatitis B Virus, and Hepatitis C Virus Among Prisoners in Pakistan

Overview
Publisher Elsevier
Date 2010 Mar 2
PMID 20189863
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The objective of this study was to evaluate the burden of sexual- and injection drug use-related infections in male prisoners in Karachi, Pakistan.

Methods: We administered a structured questionnaire in a cross-sectional survey of 365 randomly selected imprisoned men. We analyzed blood for the human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) by ELISA, and for syphilis by rapid plasma reagin with Treponema pallidum hemagglutination assay confirmation. Subjects with possible tuberculosis (World Health Organization criteria) provided sputum samples for an acid-fast bacillus smear and culture.

Results: The prevalence of tuberculosis was 2.2% (95% CI 0.71-3.8%). Of 357 of the randomly selected prisoners (eight refused to give blood), 2.0% (95% CI 0.6-3.4) were HIV-infected; syphilis was confirmed in 8.9% (95% CI 6.0-11.8%), HBV in 5.9% (95% CI 3.5-8.3%), and HCV in 15.2% (95% CI 11.7-18.8). By self-report, 59.2% had used any illicit drugs, among whom 11.8% (95% CI 8.5-15.0) had injected drugs. The median length of stay in the prison had been 3.2 (range 1-72) months.

Conclusions: All four infections were prevalent among the prisoners in Pakistan. Prisons are excellent venues for infectious disease screening and intervention given the conditions of poverty and drug addiction. Collaboration with community-based health providers is vital for post-discharge planning.

Citing Articles

A Health Systems Strengthening Approach to Address the High Burden of Hepatitis C in Pakistan.

Qureshi M J Viral Hepat. 2024; 32(1):e14050.

PMID: 39707991 PMC: 11662946. DOI: 10.1111/jvh.14050.


Viral Hepatitis B and C Prevalence and Related Risk Factors Among Prisons in Duhok City, Kurdistan Region, Iraq.

Abdulrahman M, Shahab F, Khaleel B, Abdullah I, Abdulkarim N Cureus. 2024; 16(11):e73153.

PMID: 39512803 PMC: 11540890. DOI: 10.7759/cureus.73153.


Non-injection drug use among incarcerated people in Iran: Findings from three consecutive national bio-behavioral surveys.

Rafiee M, Karamouzian M, Sharifi M, Mirzazadeh A, Khezri M, Haghdoost A Harm Reduct J. 2024; 21(1):147.

PMID: 39138501 PMC: 11323345. DOI: 10.1186/s12954-024-01072-0.


Global prevalence and predictors of scabies among prisoners: systematic review and meta-analysis.

Delie A, Bogale E, Anagaw T, Tiruneh M, Fenta E, Adal O BMC Public Health. 2024; 24(1):1894.

PMID: 39010037 PMC: 11251225. DOI: 10.1186/s12889-024-19401-0.


Pakistan's HIV high-risk populations: Critical appraisal of failure to curtail spread beyond key populations.

Raza H, Raja M, Khakwani M, Jamil B IJID Reg. 2024; 11:100364.

PMID: 38660580 PMC: 11039346. DOI: 10.1016/j.ijregi.2024.100364.


References
1.
Wong M, Leung C, Tam C, Kam K, Ma C, Au K . TB surveillance in correctional institutions in Hong Kong, 1999-2005. Int J Tuberc Lung Dis. 2008; 12(1):93-8. View

2.
Fialho M, Messias M, Page-Shafer K, Farre L, Schmalb M, Pedral-Sampaio D . Prevalence and risk of blood-borne and sexually transmitted viral infections in incarcerated youth in Salvador, Brazil: opportunity and obligation for intervention. AIDS Behav. 2008; 12(4 Suppl):S17-24. DOI: 10.1007/s10461-008-9409-x. View

3.
Hussain H, Akhtar S, Nanan D . Prevalence of and risk factors associated with Mycobacterium tuberculosis infection in prisoners, North West Frontier Province, Pakistan. Int J Epidemiol. 2003; 32(5):794-9. DOI: 10.1093/ije/dyg247. View

4.
Clark M, Cameron D . Health of prisoners, and the public health: no man is an island. J Int Assoc Physicians AIDS Care (Chic). 2004; 3(2):44. DOI: 10.1177/154510970400300201. View

5.
Bick J . Infection control in jails and prisons. Clin Infect Dis. 2007; 45(8):1047-55. DOI: 10.1086/521910. View